Delivery Order SPE2DX22D0049-SPE2D826FA3MP
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,157.17 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and calls for performance in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $928K by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, the company's corporate headquarters location. The delivery order represents a task order under a larger Indefinite Delivery Contract vehicle with the DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award on January 12, 2026, valued at $49,104.00 from the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of January 13, 2026, represents a competitively awarded non-set-aside transaction. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order is...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $27,771.66 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor and represents a continuation of the company's role as a critical federal medical supply vendor. The contract will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $56,115.36 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen's corporate office is headquartered. This...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $17,649.93 by the Defense Logistics Agency's Medical Supply Chain on January 10, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,593.82 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,104.30 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is Conshohocken, Pennsylvania, with an...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA3MPDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $61,909.60 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by January 13, 2026 and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract history with the Defense Logistics Agency demonstrates its capability to meet competitive procurement requirements and efficiently fulfill essential pharmaceutical and medical supply needs for military treatment facilities and other federal medical institutions. As the parent company, Cencora, Inc. also maintains a separate $999,999,999.00 IDC with DLA Troop Support Medical through December 2031, further underscoring the company's significant role in supporting government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.9k | 1/11/26 |